申请人:Institut Pasteur
公开号:EP2272510A1
公开(公告)日:2011-01-12
The present invention relates to a new class of compounds of the general Formula (i):
wherein R1 is selected from the group consisting of: a substituted or unsubstituted C1-C10 alkyl group and a polar atom selected from the group consisting of: oxygen, nitrogen, sulfur or halogen atom; R2 and R3 are polar groups chosen from the group consisting of: =O, =NH, -NH2, -OH, =S, -X1 wherein X1 is a halogen atom; and isomers thereof, which can in particular be used as inhibitors of Proline Racemase, as a medicament and as a component of a pharmaceutical composition.
Also disclosed are in silico methods to determine inhibitors of a target using a novel structural progression approach.
本发明涉及一类新的通式(i)化合物:
其中,R1 选自以下组成的组:取代或未取代的 C1-C10 烷基和选自以下组成的组的极性原子:氧、氮、硫或卤素原子;R2 和 R3 为选自以下组成的组的极性基团:=O、=NH、-NH2、-OH、=S、-X1(其中 X1 为卤素原子);及其异构体,尤其可用作脯氨酸加酶抑制剂、药物和药物组合物的组分。
此外,还公开了利用新型结构进展方法确定靶标抑制剂的硅学方法。